Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,641,000 | 3,343,000 | 2,183,000 | 10,081,000 | 3,182,000 |
| Marketable Securities | 19,649,000 | 32,779,000 | 30,225,000 | 22,318,000 | 23,270,000 |
| Receivables | 8,176,000 | 8,401,000 | 9,357,000 | 10,675,000 | 13,058,000 |
| Inventories | 7,513,000 | 5,663,000 | 6,166,000 | 6,076,000 | 6,610,000 |
| Income taxes - deferred | N/A | 2,566,000 | 4,624,000 | 6,170,000 | N/A |
| Other current assets | 4,825,000 | 2,843,000 | 3,689,000 | 9,511,000 | 14,697,000 |
| TOTAL | $43,804,000 | $55,595,000 | $56,244,000 | $64,831,000 | $60,817,000 |
| Non-Current Assets | |||||
| PPE Net | 13,766,000 | 11,762,000 | 12,397,000 | 13,213,000 | 15,921,000 |
| Investments And Advances | 15,999,000 | 17,518,000 | 16,406,000 | 14,149,000 | 9,814,000 |
| Intangibles | 88,598,000 | 77,235,000 | 81,904,000 | 88,807,000 | 95,753,000 |
| Other Non-Current Assets | 5,214,000 | 5,457,000 | 5,150,000 | 4,798,000 | 5,697,000 |
| TOTAL | $123,577,000 | $111,972,000 | $115,857,000 | $120,967,000 | $127,185,000 |
| Total Assets | $167,381,000 | $167,566,000 | $172,101,000 | $185,798,000 | $188,002,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,159,000 | 5,141,000 | 6,027,000 | 6,424,000 | 4,016,000 |
| Accounts payable and accrued liabilities | 3,620,000 | 3,210,000 | 3,234,000 | 2,921,000 | 3,678,000 |
| Accrued Expenses | 2,359,000 | 1,841,000 | 1,792,000 | 1,875,000 | 2,120,000 |
| Other current liabilities | 10,990,000 | 9,153,000 | 9,972,000 | 13,812,000 | 15,066,000 |
| TOTAL | $29,399,000 | $21,587,000 | $23,366,000 | $29,186,000 | $28,909,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 28,740,000 | 31,541,000 | 30,462,000 | 31,036,000 | 34,926,000 |
| Other Non-Current Liabilities | 17,342,000 | 19,468,000 | 15,994,000 | 22,677,000 | 22,645,000 |
| TOTAL | $72,985,000 | $74,358,000 | $72,115,000 | $74,934,000 | $76,472,000 |
| Total Liabilities | $102,384,000 | $95,944,000 | $95,481,000 | $104,120,000 | $105,381,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 6,184,140 | 6,128,856 | 6,382,925 | 7,189,062 | 7,538,520 |
| Common Shares | 459,000 | 455,000 | 453,000 | 448,000 | 445,000 |
| Retained earnings | 71,993,000 | 72,176,000 | 69,732,000 | 54,240,000 | 46,210,000 |
| Other shareholders' equity | -9,218,000 | -6,965,000 | -2,925,000 | -5,496,000 | -3,656,000 |
| TOTAL | $64,998,000 | $71,622,000 | $76,620,000 | $81,678,000 | $82,621,000 |
| Total Liabilities And Equity | $167,382,000 | $167,566,000 | $172,101,000 | $185,798,000 | $188,002,000 |